4-Nonylphenol-enhanced EZH2 and RNF2 expression, H3K27me3 and H2AK119ub1 marks resulting in silencing of p21CDKN1A in vitro

被引:9
|
作者
Ghosh, Krishna [1 ]
Chatterjee, Biji [1 ]
Maheswari, Uma [2 ]
Athifa, Mariyam [1 ]
Kanade, Santosh R. [1 ,3 ]
机构
[1] Cent Univ Kerala, Dept Biochem & Mol Biol, Sch Biol Sci, Kasaragod 671316, Kerala, India
[2] Pondicherry Univ, Dept Biochem & Mol Biol, Sch Life Sci, Kalapet 605014, Puducherry, India
[3] Univ Hyderabad, Dept Plant Sci, Sch Life Sci, Prof CR Rao Rd, Hyderabad 500046, Telangana, India
关键词
BMI1; CDKN1A/p21/WAF1; E2F-1; endocrine disruptor (EDC); enhancer of zeste homolog 1/2 (EZH1/2); E3 ubiquitin-protein ligase RING1 (RING1A/RING1B); EZH2; H2AK119ub1; H3K27me3; 4-nonylphenol (4-NP); polycomb repressive complex (PRC); RNF2; SP1; suppressor of zeste 12 homolog (SUZ12); SUZ12; ENDOCRINE-DISRUPTING CHEMICALS; EPIGENETIC REGULATION; MOLECULAR-MECHANISMS; CELL-CYCLE; NONYLPHENOL; BINDING; PROTEINS; GROWTH;
D O I
10.2217/epi-2018-0175
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: To examine the impact of 4-nonylphenol (4-NP), on the expression of polycomb repressive complexes and cellular proliferation. Materials & methods: Cell proliferation assays, quantitative PCR, Western blotting, luciferase reporter assay, chromatin immunoprecipitation-quantitative PCR were used for the study. Results: The 4-NP at 100 nM concentration significantly increased proliferation of MCF-7 cells. It enhanced the expression of RNF2-BMI1 and EZH2-SUZ12 and concomitantly increased H2AK119ub1 and H3K27me3 repressive marks at p21 proximal promoter resulting in its reduced expression. Selective inhibition of RNF2 or EZH2 reverted the 4-NP action. The phospho-CREB, SP1 and E2F-1 are enriched at proximal promoter of RNF2 and EZH2 and cyclin D1, but not p21. Conclusion: The 4-NP-mediated upregulation of RNF2 and EZH2 resulted in epigenetic silencing of p21.
引用
收藏
页码:899 / 916
页数:18
相关论文
共 50 条
  • [21] DZNep attenuates liver fibrosis by blocking EZH2 and H3K27me3
    Zeybel, Mujdat
    Walsh, Meagan J.
    Chu, David C.
    Tsukamoto, Hidekazu
    Mann, Derek A.
    Mann, Jelena
    HEPATOLOGY, 2012, 56 : 772A - 772A
  • [22] Inhibition of Ezh2 In Vitro and the Decline of Ezh2 in Developing Midbrain Promote Dopaminergic Neurons Differentiation Through Modifying H3K27me3
    Hong, Feng
    Zhao, Mengxue
    Zhang, Lei
    Feng, Linyin
    STEM CELLS AND DEVELOPMENT, 2019, 28 (10) : 649 - 658
  • [23] Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer
    Sónia Carvalho
    Micaela Freitas
    Luís Antunes
    Sara Monteiro-Reis
    Marcia Vieira-Coimbra
    Ana Tavares
    Sofia Paulino
    José Flávio Videira
    Carmen Jerónimo
    Rui Henrique
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2127 - 2137
  • [24] Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer
    Carvalho, Sonia
    Freitas, Micaela
    Antunes, Luis
    Monteiro-Reis, Sara
    Vieira-Coimbra, Marcia
    Tavares, Ana
    Paulino, Sofia
    Videira, Jose Flavio
    Jeronimo, Carmen
    Henrique, Rui
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (11) : 2127 - 2137
  • [25] Differential Expression of EZH2 and H3K27me3 in Oral Verrucous Carcinoma and Oral Verrucous Hyperplasia
    Sihavong, Phetmany
    Kitkumthorn, Nakarin
    Srimaneekarn, Natchalee
    Bumalee, Dusit
    Lapthanasupkul, Puangwan
    HEAD & NECK PATHOLOGY, 2021, 15 (02): : 408 - 415
  • [26] Expression patterns of EZH2 and H3K27me3 in human colon cancer and their relationship with clinicopathological characteristics
    Zhou, Qingquan
    Hao, Jianbo
    You, Jin
    Li, Jiantian
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 207 - 207
  • [27] Prognostic Significance of Overexpression of EZH2 and H3k27me3 Proteins in Gastric Cancer
    He, Long-Jun
    Cai, Mu-Yan
    Xu, Guo-Liang
    Li, Jian-Jun
    Weng, Zi-Jin
    Xu, Da-Zhi
    Luo, Guang-Yu
    Zhu, Sen-Lin
    Xie, Dan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (07) : 3173 - 3178
  • [28] PROGNOSTIC VALUE OF H3K27ME3 AND EZH2 IN ASTROCYTOMA, IDH-MUTANT
    Onishi, Shumpei
    Yamasaki, Fumiyuki
    Amatya, Vishwa Jeet
    Yonezawa, Ushio
    Taguchi, Akira
    Ozono, Iori
    Khairunnisa, Novita Ikbar
    Go, Yukari
    Takeshima, Yukio
    Horie, Nobutaka
    NEURO-ONCOLOGY, 2024, 26
  • [29] Differential Expression of EZH2 and H3K27me3 in Oral Verrucous Carcinoma and Oral Verrucous Hyperplasia
    Phetmany Sihavong
    Nakarin Kitkumthorn
    Natchalee Srimaneekarn
    Dusit Bumalee
    Puangwan Lapthanasupkul
    Head and Neck Pathology, 2021, 15 : 408 - 415
  • [30] EZH2-mediated H3K27me3 inhibits ACE2 expression
    Li, Yuanyuan
    Li, Honggang
    Zhou, Liquan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 526 (04) : 947 - 952